Serbian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Страна 1 од 216 резултати
Serum chromium in patients with recent and old myocardial infarction.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The serum chromium in 45 subjects with no clinical evidence of ischemic heart disease was found to be 1.71 parts per billion (ppb) (S.E. +/- 0.14). In 34 patients with a previously documented myocardial infarction, it was 1.84 ppb (S.E. +/- 0.18). The difference was not significant nor was there any
Comparing the use of cobalt chromium stents to stainless steel stents in primary percutaneous coronary intervention for acute myocardial infarction: a prospective registry.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
To determine clinical outcome and rates of target vessel revascularization (TVR) in patients undergoing primary percutaneous coronary intervention (PCI) for STEMI who were treated with cobalt-chromium stents compared to stainless steel bare metal stents (BMS).
BACKGROUND
The newer
Cadmium, cobalt, chromium, and experimental myocardial infarction.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
In the case of experimental heart muscle infarction, the infarcted tissue of 18 pigs had a cadmium content of 0.38 μg/g dry weight and a cobalt content of 0.45 μg/g dry weight. In 25 non-infarcted pig hearts, the cadmium concentration amounted to 0.27 μg/g dry weight and the cobalt concentration to
Periprocedural (30-day) risk of myocardial infarction after drug-eluting coronary stent implantation: a meta-analysis comparing cobalt-chromium and stainless steel drug-eluting coronary stents.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
Because of the reduction in the rate events related with in-stent restenosis, most events after drug-eluting stent implantation occur shortly after coronary stenting. Cobalt-chromium alloys allow to reduce strut thickness and improve flexibility and deliverability of coronary stent
Low toenail chromium concentration and increased risk of nonfatal myocardial infarction.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Chromium intake may increase insulin sensitivity, glucose tolerance, and the ratio of high density lipoprotein cholesterol to low density lipoprotein cholesterol. However, the epidemiologic evidence on the association between chromium and cardiovascular disease is very limited. To determine whether
Vascular Response Occurring at 3 Months After Everolimus-Eluting Cobalt-Chromium Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction vs. Stable Coronary Artery Disease
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Background: Second-generation drug-eluting stents (DES) reduce the incidence of stent thrombosis, even in patients with ST-segment elevated myocardial infarction (STEMI). However, the early local vascular healing after DES implantation in
Early vascular responses to everolimus-eluting cobalt-chromium stent in the culprit lesions of st-elevation myocardial infarction: results from a multicenter prospective optical coherence tomography study (MECHANISM-AMI 2-week follow-up study).
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The use of cobalt-chromium everolimus-eluting stents (CoCr-EES) for ST-segment elevation myocardial infarction (STEMI) reduces the incidence of stent thrombosis compared with bare metal stents, and a substantial difference is apparent in the initial 2 weeks. However, vascular behavior during this
A Randomized Comparison between Everolimus-Eluting Stent and Cobalt Chromium Stent in Patients with Acute ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Using Routine Intravenous Eptifibatide: The X-MAN (Xience vs. Multi-Link Stent in Acute Myocardial Infarction) Trial, A Pilot Study.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The objective of this study is to determine the efficacy and safety of an everolimus-eluting stent (EES/Xience; Abbott Vascular, Santa Clara, CA) compared with a cobalt chromium stent (CoCr/Multi-Link Vision; Abbott Vascular) in patients with acute ST-elevation myocardial infarction (STEMI)
Rationale and design of the EXAMINATION trial: a randomised comparison between everolimus-eluting stents and cobalt-chromium bare-metal stents in ST-elevation myocardial infarction.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
To assess the performance of the everolimus-eluting stent (EES) versus cobalt chromium bare-metal stent (BMS) in the setting of primary percutaneous coronary intervention for treatment of patients presenting with ST-segment elevation myocardial infarction (STEMI). The implantation of a
Chromium and manganese levels in biological samples of Pakistani myocardial infarction patients at different stages as related to controls.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
It has been speculated that trace elements may play a role in the pathogenesis of heart diseases In the present study, we aimed to access the levels of chromium (Cr) and manganese (Mn) in biological samples (whole blood, urine, and scalp hair) of myocardial infarction (MI) patients of both gender
Preventive effects of selenium yeast, chromium picolinate, zinc sulfate and their combination on oxidative stress, inflammation, impaired angiogenesis and atherogenesis in myocardial infarction in rats.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
Accumulating evidences suggest a critical role of trace metal dyshemostasis in oxidative stress and cardiac dysfunction after myocardial infarction (MI). This study investigated the cardioprotective effects of selenium yeast (Se), chromium picolinate Cr(pic)3, zinc sulfate (Zn) and their
Randomized comparison of endothelial progenitor cells capture stent versus cobalt-chromium stent for treatment of ST-elevation myocardial infarction. Six-month clinical, angiographic, and IVUS follow-up.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
The aim of this trial was to assess the feasibility and safety of endothelial progenitor cells capture (EPC) stent in the treatment of acute ST-elevation myocardial infarction (STEMI) when compared with cobalt-chromium stents (CoCr).
METHODS
Between July 2006 and May 2008, 100 patients
Chromium supplementation improved post-stroke brain infarction and hyperglycemia.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Hyperglycemia is common after acute stroke and is associated with a worse outcome of stroke. Thus, a better understanding of stress hyperglycemia is helpful to the prevention and therapeutic treatment of stroke. Chromium is an essential nutrient required for optimal insulin activity and normal
Performance of bioresorbable vascular scaffolds versus cobalt-chromium everolimus-eluting stent in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: a review of currently available clinical data.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Bioresorbable vascular scaffold (BVS) represents a breakthrough in interventional cardiology. Despite BVS is used in various settings, nowadays only few studies compared BVS outcome with everolimus-eluting stent (EES) in ST-elevation myocardial infarction. We analyzed the currently available
[Changes in erythrocyte properties in myocardial infarct according to data from the saponin test and studies with radioactive chromium].
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Најкомплетнија база лековитог биља подржана науком
- Ради на 55 језика
- Биљни лекови потпомогнути науком
- Препознавање биљака по слици
- Интерактивна ГПС мапа - означите биље на локацији (ускоро)
- Читајте научне публикације повезане са вашом претрагом
- Претражите лековито биље по њиховим ефектима
- Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима
Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима
